DM0000: The mark consists of the stylized wording "NIPD GENETICS" in gray above "NEOSENTIA" with "NEO" in red and "SENTIA" in gray, above "LIQUID BIOPSY CANCER" in gray.
CC0000: The color(s) gray and red is/are claimed as a feature of the mark.
GS0011: Kits composed of reagents for genetic testing for medical and scientific research purposes; kits composed of reagents for genetic testing for medical and scientific research purposes in the field of oncology; kits composed of reagents for cancer diagnosis and prognosis for medical and scientific research purposes; kits composed of reagents for testing for chromosomal or mutational abnormalities in cancer patients for medical and scientific research purposes
GS0441: Medical testing services for diagnosis of cancer; medical genetic testing; medical diagnostic testing in the field of oncology; medical testing of blood for diagnosis of genetic abnormalities such as mutations during cancer disease; medical testing for diagnosis of genetic disorders, diseases and syndromes; genetic testing for diagnostic or treatment purposes and genetic counseling in the field of cancer treatment; medical and healthcare services relating to DNA, genetics and genetic testing
D10000: "NIPD GENETICS" AND "LIQUID BIOPSY CANCER"
GS0421: Medical laboratory services for cancer testing; design and development of medical diagnostic tests and products; medical and scientific research in the field of genetic testing particularly in the field of oncology; providing medical and scientific research information in the field of genetic testing; genetic testing for scientific research and analysis purposes in the field of oncology cancer; genetic engineering services for scientific research purposes
Case File Event Statements
6/14/2023 - a year ago
39 - TEAS CHANGE OF CORRESPONDENCE RECEIVEDType:TCCA